BioXcel Therapeutics Income Statement (2017-2026) | BTAI

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B
Revenue & cost
Revenue (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Gross Profit (Quarter)
0.00B0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B-0.00B
Operating items
Research & Development (Quarter)
0.01B0.01B0.01B0.02B0.02B0.02B0.03B0.03B0.03B0.02B0.01B0.01B0.01B0.01B0.01B0.00B0.01B0.01B0.01B0.00B
Selling, General & Administrative (Quarter)
0.01B0.01B0.01B0.01B0.02B0.02B0.02B0.02B0.03B0.02B0.01B0.01B0.01B0.01B0.00B0.01B0.01B0.01B0.00B0.01B
Restructuring Costs (Quarter)
0.00B0.00B0.00B0.00B0.00B
Other Operating Expenses (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Operating Expenses (Quarter)
0.03B0.03B0.03B0.03B0.04B0.04B0.05B0.05B0.05B0.05B0.02B0.02B0.02B0.02B0.01B0.01B0.02B0.01B0.01B0.01B
Operating Income (Quarter)
-0.03B-0.03B-0.03B-0.03B-0.04B-0.04B-0.05B-0.05B-0.05B-0.05B-0.02B-0.02B-0.02B-0.02B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B
EBIT (Quarter)
-0.03B-0.03B-0.03B-0.03B-0.04B-0.04B-0.05B-0.05B-0.05B-0.05B-0.02B-0.02B-0.02B-0.02B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B
Non-operating items
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter)
0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B0.01B0.00B0.00B0.01B0.00B-0.01B0.00B0.00B
Non Operating Income (Quarter)
0.00B0.00B
Net income details
EBT (Quarter)
-0.03B-0.09B-0.03B-0.08B-0.06B-0.06B-0.17B-0.09B-0.06B-0.05B-0.02B-0.03B-0.02B-0.02B-0.01B-0.01B-0.02B-0.02B-0.01B-0.01B
Profit After Tax (Quarter)
-0.03B-0.03B-0.03B-0.03B-0.04B-0.04B-0.05B-0.05B-0.05B-0.05B-0.02B-0.03B-0.01B-0.01B-0.01B-0.01B-0.02B-0.03B-0.01B-0.01B
Income from Continuing Operations (Quarter)
-0.03B-0.09B-0.03B-0.08B-0.06B-0.06B-0.17B-0.09B-0.06B-0.05B-0.02B-0.03B-0.02B-0.02B-0.01B-0.01B-0.02B-0.02B-0.01B-0.01B
Consolidated Net Income (Quarter)
-0.03B-0.09B-0.03B-0.08B-0.06B-0.06B-0.17B-0.09B-0.06B-0.05B-0.02B-0.03B-0.02B-0.02B-0.01B-0.01B-0.02B-0.02B-0.01B-0.01B
Income towards Parent Company (Quarter)
-0.03B-0.09B-0.03B-0.08B-0.06B-0.06B-0.17B-0.09B-0.06B-0.05B-0.02B-0.03B-0.02B-0.02B-0.01B-0.01B-0.02B-0.02B-0.01B-0.01B
Net Income towards Common Stockholders (Quarter)
-0.03B-0.09B-0.03B-0.08B-0.06B-0.06B-0.17B-0.09B-0.06B-0.05B-0.02B-0.03B-0.02B-0.02B-0.01B-0.01B-0.02B-0.02B-0.01B-0.01B
Additional items
EPS (Basic) (Quarter)
-17.70-53.42-15.85-44.69-34.16-33.42-96.97-47.67-32.90-29.82-12.12-13.90-8.08-6.97-2.86-2.86-2.53-1.26-1.18-0.60
EPS (Diluted) (Quarter)
-17.70-53.42-15.85-44.69-34.16-33.42-96.97-0.00B-32.90-29.82-12.12-13.90-8.08-6.97-2.86-2.86-2.53-1.26-1.18-0.60
Shares Outstanding (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.02B
Shares Outstanding (Diluted) (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.02B
EBITDA (Quarter)
-0.03B-0.03B-0.03B-0.03B-0.04B-0.04B-0.05B-0.05B-0.05B-0.05B-0.02B-0.02B-0.02B-0.02B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B
Interest Expenses (Quarter)
0.00B0.07B0.00B0.05B0.02B0.02B0.12B0.04B0.01B0.01B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B